Telangana Attracts 54,000 Cr, Rises in Global Life Sciences

With investments of over Rs. 54,000 crore in the last year alone, Telangana has once again established itself as a global leader in the life sciences, and the city is currently listed among the top 7 life sciences clusters worldwide

ICMR Study Finds Better Nutrition Helps Reduce TB Cases in India

A big study paid for by the Indian Council of Medical Research (ICMR) found that better food cuts down on tuberculosis (TB) cases and deaths a lot.

AIIMS Study Reveals High Rate of Catheter-Linked Infections in India

Bloodstream infections that come from using catheters in the hospital are common in the ICU in India. They are often caused by germs that fight off drugs

Merck KGaA and Skyhawk Partner to Develop RNA-Targeting Drugs

With a focus on finding new RNA-targeting small molecules in specific neurological indications with high unmet medical need, Skyhawk Therapeutics, a leader in the discovery and development of small molecules that modulate RNA expression, announces

Alembic Pharma Gets USFDA Nod for Pulmonary Hypertension Drug Macitentan

Alembic Pharmaceuticals Limited announced that the US Food and Drug Administration (USFDA) gave its final approval to their Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg.

Natureoroma Launches Squacare Gel for Oral Submucous Fibrosis Patients

Natureoroma, based in Ramanagaram in the south of Bengaluru, has made Squacare, a gel for the mouth, made to help folks with oral submucous fibrosis (OSMF).

Glenmark Launches Micafungin Injection in US Market

Glenmark Pharmaceuticals Inc. is officially announced to implement the launch1 of Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) from Glenmark Pharmaceuticals Inc., USA (Glenmark)

Future of Indian Healthcare Is Proactive and Tech-Driven, Says Lovekesh Phasu

India's health care must change to be proactive, use tech, and focus on what people need, said Lovekesh Phasu, top worker at Sakra World Hospital.

Accord BioPharma Launches Imuldosa Prefilled Syringes at Lowest WAC

Accord BioPharma, Inc., the U.S. arm of Intas Pharmaceuticals, Ltd., has rolled out Imuldosa (ustekinumab-srlf), a match to Stelara (ustekinumab). Sold in ready-to-use syringes and vials, Imuldosa hits the market with the lowest cost

India Targets Global Pharma Leadership with R&D & Policy Support

On August 18, 2025, Union Commerce and Industry Minister Piyush Goyal met with leaders from the pharmaceutical industry in New Delhi to discuss how to develop India's pharmaceuticals industry by boosting research and development and better...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.